PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Consultant Endocrinologist, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India. Electronic address: drawadheshkumarsingh@gmail.com.\', \'Consultant Physician & Diabetologist, Vijayratna Diabetes Centre, Ahmedabad, Gujarat, India.\', \'Consultant Gynecologist, G. D Hospital & Diabetes Institute, Kolkata, West Bengal, India.\', \'Independent Biostatistician, Kolkata, West Bengal, India.\', \'Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India.\', \'Head, Department of Diabetes, Obesity and Metabolic Disorders, Rajasthan Hospital, Jaipur, Rajasthan, India.\', \'Associate Professor, Dept. of Community Medicine, Mahatma Gandhi Medical College & Hospital, Jaipur, Rajasthan, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01258-510.1016/j.vaccine.2021.09.055
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34600747
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all